Paxlovid not helpful for reducing most post-COVID-19 conditions
Oct 31, 2023
No differences were seen in most post-COVID-19 conditions examined individually or by organ system, apart from a lower combined risk for venous thromboembolism and pulmonary embolism.
COVID-19 meds like Paxlovid will soon have big price tags
Oct 30, 2023
The pills still will be available at no cost until those bought earlier by the federal government run out.
Fluticasone furoate does not cut time to COVID-19 symptom resolution
Sep 21, 2023
No significant reduction was seen in the percent of patients with urgent care or emergency department visits or hospitalization.
Practice points developed for treatment of outpatient COVID-19
Sep 20, 2023
Molnupiravir and nirmatrelvir-ritonavir combination therapy should be considered for patients within five days of symptom onset.
Study looks at links between anxiety disorders, benzodiazepines, dementia
Aug 14, 2023
Benzodiazepines and anxiety disorders were linked to dementia risk, but no additional risk was seen for benzodiazepines in patients with anxiety disorders.
Solanezumab does not slow cognitive decline in preclinical Alzheimer’s disease
Jul 19, 2023
The mean change in Preclinical Alzheimer Cognitive Composite score not significantly different at 240 weeks with solanezumab or placebo.
Hey, doc, can we get a prescription for air-conditioning? For heat-threatened seniors, the answer could...
By
Aaron Dorman
Jul 19, 2023
Prescription air conditioning is one of several novel potential solutions put forth in a new report about how providers in states like Texas and Arizona can protect those most vulnerable to heat-related...
CMS announces Alzheimer’s drug coverage policy, but ‘the devil is in the details,’ experts say
By
Kimberly Bonvissuto
Jun 01, 2023
A Thursday announcement by the Centers for Medicare & Medicaid Services regarding coverage of Alzheimer’s drugs is being met with skepticism by some industry advocates who say that “the devil is in...
Inconsistent state regulations, staff training produce wide variations among states’ antipsychotic...
By
Kimberly Bonvissuto
Feb 28, 2023
Researchers are calling for a closer look at the use of antipsychotics among assisted living residents with dementia after a study found wide variations in prescribing patterns.
Feds’ antipsychotic drug reduction efforts in assisted living fail to produce success seen in nursing...
By
Alicia Lasek
Aug 23, 2022
A federal initiative to reduce antipsychotic prescribing in long-term care facilities failed to impact prescriptions in assisted living residents with dementia, the first study of its kind has found.